pdufa.bio

AVLAYAH (Tividenofusp alfa)

Updated ยทnext FDA decision on the calendar

AVLAYAH (Tividenofusp alfa) 1 FDA decision on record below. Every date links its source.

DNLI catalyst hub

About this program

We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Mar 25, 2026 ✓ ApprovedDNLI

Questions

When is AVLAYAH (Tividenofusp alfa)'s next FDA decision or readout?

No upcoming catalyst is on our calendar for AVLAYAH (Tividenofusp alfa); 1 FDA decision is on record below.

What happened at AVLAYAH (Tividenofusp alfa)'s most recent FDA decision?

On Mar 25, 2026 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.